Literature DB >> 32132218

Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection.

Louise Leyre1, Eugène Kroon2, Claire Vandergeeten3, Carlo Sacdalan2, Donn J Colby2, Supranee Buranapraditkun4, Alexandra Schuetz5,6,7, Nitiya Chomchey2, Mark de Souza2, Wendy Bakeman3, Rémi Fromentin1, Suteeraporn Pinyakorn6,7, Siriwat Akapirat5, Rapee Trichavaroj5, Suthat Chottanapund2, Sopark Manasnayakorn4, Rungsun Rerknimitr4, Phandee Wattanaboonyoungcharoen4, Jerome H Kim8, Sodsai Tovanabutra6,7, Timothy W Schacker9, Robert O'Connell5,7, Victor G Valcour10, Praphan Phanuphak2,4, Merlin L Robb6,7, Nelson Michael7, Lydie Trautmann6,7, Nittaya Phanuphak2, Jintanat Ananworanich6,7,11, Nicolas Chomont12.   

Abstract

The timing and location of the establishment of the viral reservoir during acute HIV infection remain unclear. Using longitudinal blood and tissue samples obtained from HIV-infected individuals at the earliest stage of infection, we demonstrate that frequencies of infected cells reach maximal values in gut-associated lymphoid tissue and lymph nodes as early as Fiebig stage II, before seroconversion. Both tissues displayed higher frequencies of infected cells than blood until Fiebig stage III, after which infected cells were equally distributed in all compartments examined. Initiation of antiretroviral therapy (ART) at Fiebig stages I to III led to a profound decrease in the frequency of infected cells to nearly undetectable level in all compartments. The rare infected cells that persisted were preferentially found in the lymphoid tissues. Initiation of ART at later stages (Fiebig stages IV/V and chronic infection) induced only a modest reduction in the frequency of infected cells. Quantification of HIV DNA in memory CD4+ T cell subsets confirmed the unstable nature of most of the infected cells at Fiebig stages I to III and the emergence of persistently infected cells during the transition to Fiebig stage IV. Our results indicate that although a large pool of cells is infected during acute HIV infection, most of these early targets are rapidly cleared upon ART initiation. Therefore, infected cells present after peak viremia have a greater ability to persist.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Year:  2020        PMID: 32132218      PMCID: PMC7293182          DOI: 10.1126/scitranslmed.aav3491

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  78 in total

1.  Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro.

Authors:  Kersten K Koelsch; Lin Liu; Richard Haubrich; Susanne May; Diane Havlir; Huldrych F Günthard; Caroline C Ignacio; Paula Campos-Soto; Susan J Little; Robert Shafer; Gregory K Robbins; Richard T D'Aquila; Yuji Kawano; Karen Young; Phillip Dao; Celsa A Spina; Douglas D Richman; Joseph K Wong
Journal:  J Infect Dis       Date:  2008-02-01       Impact factor: 5.226

Review 2.  Developing strategies for HIV-1 eradication.

Authors:  Christine M Durand; Joel N Blankson; Robert F Siliciano
Journal:  Trends Immunol       Date:  2012-08-03       Impact factor: 16.687

3.  Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane.

Authors:  Zheng Wang; Evelyn E Gurule; Timothy P Brennan; Jeffrey M Gerold; Kyungyoon J Kwon; Nina N Hosmane; Mithra R Kumar; Subul A Beg; Adam A Capoferri; Stuart C Ray; Ya-Chi Ho; Alison L Hill; Janet D Siliciano; Robert F Siliciano
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-26       Impact factor: 11.205

4.  Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials.

Authors:  Angela M Mexas; Erin H Graf; Matthew J Pace; Jianqing J Yu; Emmanouil Papasavvas; Livio Azzoni; Michael P Busch; Michele Di Mascio; Andrea S Foulkes; Stephen A Migueles; Luis J Montaner; Una O'Doherty
Journal:  AIDS       Date:  2012-11-28       Impact factor: 4.177

Review 5.  The detection of acute HIV infection.

Authors:  Myron S Cohen; Cynthia L Gay; Michael P Busch; Frederick M Hecht
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

6.  Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART.

Authors:  Ann Wiegand; Jonathan Spindler; Feiyu F Hong; Wei Shao; Joshua C Cyktor; Anthony R Cillo; Elias K Halvas; John M Coffin; John W Mellors; Mary F Kearney
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-17       Impact factor: 11.205

7.  Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study.

Authors:  Julian H Elliott; James H McMahon; Christina C Chang; Sulggi A Lee; Wendy Hartogensis; Namandje Bumpus; Rada Savic; Janine Roney; Rebecca Hoh; Ajantha Solomon; Michael Piatak; Robert J Gorelick; Jeff Lifson; Peter Bacchetti; Steven G Deeks; Sharon R Lewin
Journal:  Lancet HIV       Date:  2015-11-17       Impact factor: 12.767

8.  Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.

Authors:  T W Chun; D Engel; M M Berrey; T Shea; L Corey; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

9.  Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation.

Authors:  Alexandra Schuetz; Claire Deleage; Irini Sereti; Rungsun Rerknimitr; Nittaya Phanuphak; Yuwadee Phuang-Ngern; Jacob D Estes; Netanya G Sandler; Suchada Sukhumvittaya; Mary Marovich; Surat Jongrakthaitae; Siriwat Akapirat; James L K Fletscher; Eugene Kroon; Robin Dewar; Rapee Trichavaroj; Nitiya Chomchey; Daniel C Douek; Robert J O Connell; Viseth Ngauy; Merlin L Robb; Praphan Phanuphak; Nelson L Michael; Jean-Louis Excler; Jerome H Kim; Mark S de Souza; Jintanat Ananworanich
Journal:  PLoS Pathog       Date:  2014-12-11       Impact factor: 6.823

10.  Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.

Authors:  N M Archin; A L Liberty; A D Kashuba; S K Choudhary; J D Kuruc; A M Crooks; D C Parker; E M Anderson; M F Kearney; M C Strain; D D Richman; M G Hudgens; R J Bosch; J M Coffin; J J Eron; D J Hazuda; D M Margolis
Journal:  Nature       Date:  2012-07-25       Impact factor: 49.962

View more
  27 in total

Review 1.  The multifaceted nature of HIV latency.

Authors:  Caroline Dufour; Pierre Gantner; Rémi Fromentin; Nicolas Chomont
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 2.  The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies.

Authors:  Lillian B Cohn; Nicolas Chomont; Steven G Deeks
Journal:  Cell Host Microbe       Date:  2020-04-08       Impact factor: 21.023

3.  Hide and seek: for HIV-infected CD4+ T cells, playing well comes with maturity.

Authors:  Louise Leyre; R Brad Jones
Journal:  J Clin Invest       Date:  2022-04-01       Impact factor: 14.808

4.  An Optimized Tat/Rev Induced Limiting Dilution Assay for the Characterization of HIV-1 Latent Reservoirs.

Authors:  Swarnima Mishra; Yuvrajsinh Gohil; Kavita Mehta; Anish D'silva; Afzal Amanullah; Deepak Selvam; Neelam Pargain; Narendra Nala; G N Sanjeeva; Udaykumar Ranga
Journal:  Bio Protoc       Date:  2022-04-20

Review 5.  The Lymph Node Reservoir: Physiology, HIV Infection, and Antiretroviral Therapy.

Authors:  Erin M B Scholz; Angela D M Kashuba
Journal:  Clin Pharmacol Ther       Date:  2021-02-28       Impact factor: 6.875

Review 6.  HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs.

Authors:  Rémi Fromentin; Nicolas Chomont
Journal:  Semin Immunol       Date:  2020-11-30       Impact factor: 11.130

Review 7.  Eliminating HIV reservoirs for a cure: the issue is in the tissue.

Authors:  Kathleen Busman-Sahay; Carly E Starke; Michael D Nekorchuk; Jacob D Estes
Journal:  Curr Opin HIV AIDS       Date:  2021-07-01       Impact factor: 4.061

Review 8.  Evolution and Diversity of Immune Responses during Acute HIV Infection.

Authors:  Samuel W Kazer; Bruce D Walker; Alex K Shalek
Journal:  Immunity       Date:  2020-11-17       Impact factor: 31.745

9.  In Situ Characterization of Human Lymphoid Tissue Immune Cells by Multispectral Confocal Imaging and Quantitative Image Analysis; Implications for HIV Reservoir Characterization.

Authors:  Eirini Moysi; Perla M Del Rio Estrada; Fernanda Torres-Ruiz; Gustavo Reyes-Terán; Richard A Koup; Constantinos Petrovas
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

10.  Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation.

Authors:  Trevor A Crowell; Justin Ritz; Robert W Coombs; Lu Zheng; Joseph J Eron; John W Mellors; Joan Dragavon; Gert U van Zyl; Javier R Lama; Kiat Ruxrungtham; Beatriz Grinsztejn; Roberto C Arduino; Lawrence Fox; Jintanat Ananworanich; Eric S Daar
Journal:  Clin Infect Dis       Date:  2021-08-02       Impact factor: 20.999

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.